newsfilter
← Latest News
GlobeNewswire·

Caladrius Biosciences and Cend Therapeutics Announce Definitive Merger Agreement

Combined company to be renamed Lisata Therapeutics upon transaction closing Combination will create a financially sound Nasdaq-listed company with a diverse product development pipeline, strong existing partnerships and potential for future attractive